The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

This is a phase 2 study to assess the role of tumor histogenesis (subtype), fluorodeoxyglucose positron emission tomography (FDG-PET), and short-course etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin with dose-dense rituximab (SC-EPOCH-RR) in newly diagnosed HIV-associated CD20...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dunleavy, Kieron, Little, Richard F., Pittaluga, Stefania, Grant, Nicole, Wayne, Alan S., Carrasquillo, Jorge A., Steinberg, Seth M., Yarchoan, Robert, Jaffe, Elaine S., Wilson, Wyndham H.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2010
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858473/
https://ncbi.nlm.nih.gov/pubmed/20130244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-11-253039
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares